Sanofi
Search results
UCB is an international company with revenue of €4.178 billion in 2016 which focuses primarily on research and development, specifically involving medications centered on epilepsy, Parkinson's disease, and Crohn's disease.
At UCB, we believe that everyone deserves to live the best life that they can. That’s why – as a global biopharmaceutical leader - we’re focused on creating valuable solutions that make improvements to the lives of people living with neurological and autoimmune conditions now and into the future.
A global biopharma company, inspired by the needs of people living with severe diseases. At UCB, we are consistently delivering on our commitment to improve the lives of people living with severe neurological and immunological conditions.
UCB – The Facts With approximately 9000 employees in around 40 countries, we are a global biopharmaceutical company headquartered in Brussels, Belgium which invests more than 25% of revenue...
UCB is a global biopharmaceutical company focused on creating value for people living with severe diseases in immunology and neurology. We work with the patients and the scientific community to find new treatments, while continuing to improve the well-being of people with chronic disease.
UCB is a global biopharmaceutical company focused on creating value for people living with severe diseases in immunology and neurology. We work with the patients and the scientific community to find new treatments, while continuing to improve the well-being of people with chronic disease.
UCB is a global biopharmaceutical company focused on creating value for people living with severe diseases in immunology and neurology. We work with the patients and the scientific community to find new treatments, while continuing to improve the well-being of people with chronic disease.
Contact details for Business Enquiry. Tel: +91 22 67004911. +91 22 67004812. Email: info.UCB-India@ucb.com.
UCB is a global biopharma company focused on creating value for people living with severe diseases. Learn more about how UCB delivers value for patients through its patient assistance program, treatment tracker and more.
At UCB, we aspire to be the patient-preferred biotech leader. To achieve this goal, UCB has become an innovation-driven global biopharmaceutical company creating value for patients, the company, its shareholders and society in general. Our work has an impact on the lives of many people.
